Raza Alvi, M.D., a research fellow in radiology at Massachusetts General Hospital, has been involved in a study of a positron-emission...
PET-CT
PET-CT combines positron emission tomography (PET) detectors and computed tomography (CT) into one imaging system.
-
-
Technological advancements in positron emission tomography/computed tomography (PET/CT) offer both clinicians and patients alike a positive outlook in nuclear medicine.
-
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S. Food & Drug Administration (FDA) clearance of the uExplorer total-body scanner.
-
June 5, 2018 — The U.S. Food and Drug Administration (FDA) has cleared the Biograph Vision, a new positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.
-
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and president-elect of the American Society of Nuclear Cardiology (ASNC), explained advances in PET and SPECT imaging and the learning curve involved in reading scans from the new CZT...
Sponsored Content
News | PET-CT | February 06, 2019
Technological advancements in positron emission tomography/computed tomography (PET/CT) offer both clinicians and...
Sponsored Content | News | PET-CT | February 06, 2019
Technological advancements in positron emission tomography/computed tomography (PET/CT) offer both clinicians and...
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S. Food & Drug Administration (FDA)...
A 90-second brain acquisition with FDG radiotracer — comparison of digital (Vereos, left, 1 mm) and conventional (Gemini TF, 4 mm) images.
Sponsored Content | Blog | PET Imaging | December 11, 2018
Digital technology is opening remarkable opportunities for clinical...
Sponsored Content
A 90-second brain acquisition with FDG radiotracer — comparison of digital (Vereos, left, 1 mm) and conventional (Gemini TF, 4 mm) images.
Blog | PET Imaging | December 11, 2018
Digital technology is opening remarkable opportunities for clinical...
News | Artificial Intelligence | December 04, 2018
December 4, 2018 — Mirada Medical, a leading global brand in medical imaging software, will form part of an...
News | Teleradiology | November 25, 2018
November 25, 2018 — During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North...
Staging F18FDG PET/CT images of adenocarcinoma in the RUL (right upper lobe) of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. (Images courtesy of Dr. Jay Kikut and UVMC)
Sponsored Content | Blog | PET-CT | October 25, 2018
Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the...
Sponsored Content
Staging F18FDG PET/CT images of adenocarcinoma in the RUL (right upper lobe) of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. (Images courtesy of Dr. Jay Kikut and UVMC)
Blog | PET-CT | October 25, 2018
Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both.
Each digital photon counter in the Vereos PET/CT detector contains thousands of solid-state sensors that digitally count individual photons.
Sponsored Content | Blog | PET-CT | October 17, 2018
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its...
Digital PET/CT, achieved using Vereos from Philips Healthcare, can spot even a small lesion (arrow). Image courtesy of Brian Gordon, M.D.
Sponsored Content | Blog | PET-CT | October 08, 2018
PET/CT can be indispensible as a diagnostic and prognostic tool; in the assessment of patient response to therapy...
Technology | PET-CT | September 26, 2018
September 26, 2018 — Bruker recently announced the introduction of the new preclinical...
Sponsored Content
Each digital photon counter in the Vereos PET/CT detector contains thousands of solid-state sensors that digitally count individual photons.
Blog | PET-CT | October 17, 2018
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its...
Technology | Nuclear Imaging | July 16, 2018
July 16, 2018 — At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23...
News | PET Imaging | June 25, 2018
June 25, 2018 — IMV, part of the Science and Medicine Group and a market research and business intelligence provider...
Technology | PET-CT | June 21, 2018
June 21, 2018 — Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new...
News | Prostate Cancer | June 13, 2018
June 13, 2018 — A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine...
Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.
Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S. Food and Drug Administration (FDA) has cleared the Biograph Vision, a new...
News | Computed Tomography (CT) | May 21, 2018
May 21, 2018 — The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics Acquires Worldwide Rights to Investigational Radiohybrid PSMA-Targeted Agents
May 9, 2018 — Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a...
In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows). Image courtesy of A Piccardo et al., Galliera Hospital, Genoa, Italy.
News | Prostate Cancer | March 07, 2018
An Italian study featured in the March...
